Dysthymia in neurological disorders
Dysthymia is characterized by long-lasting periods of lowered mood. Epidemiological studies in the USA and Europe have demonstrated that the prevalence of dysthymia is at least 3% of the general population. Its pervasive occurrence makes dysthymia a public health problem worldwide. One feature of th...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , , , , , , , , , , , , , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
1996
|
| Acceso en línea: | Registro en Scopus Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 20680caa a22018497a 4500 | ||
|---|---|---|---|
| 001 | PAPER-18779 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518205008.0 | ||
| 008 | 190411s1996 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-0030325019 | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a MOPSF | ||
| 100 | 1 | |a Akiskal, H.S. | |
| 245 | 1 | 0 | |a Dysthymia in neurological disorders |
| 260 | |c 1996 | ||
| 270 | 1 | 0 | |m Licinio, J.; Unit on Clinical Research, Intramural Research Program, National Institute of Mental Health, Bethesda, MD 20892-1284, United States; email: licinio@nih.gov |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a (1980) Diagnostic and Statistical Manual of Mental Disorder. (3rd Edn.), , The American Psychiatric Press: Washington, DC | ||
| 504 | |a Akiskal, H.S., Weise, R.E., The clinical spectrum of so-called minor depressions (1992) Am J Psychother, 46, pp. 9-22 | ||
| 504 | |a Akiskal, H.S., King, D., Rosenthal, T.L., Robinson, D., Scott, S.A., Chronic depressions. Part 1. Clinical and familial characteristics in 137 probands (1981) J Affect Disord, 3, pp. 297-315 | ||
| 504 | |a Akiskal, H.S., Dysthymic disorder: Psychopathology of proposed chronic depressive subtypes (1983) Am J Psychiatry, 140, pp. 11-20 | ||
| 504 | |a Akiskal, H.S., Rosenthal, T.L., Haykal, R.F., Lemmi, H., Rosenthal, R.H., Scott-Strauss, A., Characterological depressions: Clinical and sleep EEG findings separating 'subaffective dysthymias' from 'character spectrum disorders' (1980) Arch Gen Psychiatry, 37, pp. 777-783 | ||
| 504 | |a Akiskal, H.S., Dysthymia: Clinical and external validity (1994) Acta Psychiatr Scand Suppl, 383, pp. 19-23 | ||
| 504 | |a Akiskal, H.S., Dysthymia as a temperamental variant of affective disorder (1996) Eur Psychiatry, 11, pp. 117s-122s | ||
| 504 | |a De Almeida Filho, N., De Jesus Mari, J., Coutinho, E., Franca, J.F., Estudo multicentrico de morbidade psiquiatrica em areas urbanas brasileiras (Brasilia, Sao Paulo, Porto Alegre) (1992) Revista ABP-APAL, 14, pp. 93-104 | ||
| 504 | |a Lewis, A., (1979) Problems Presented by the Ambiguous Word 'Anxiety' as Used in Psychopathology, , Oxford University Press: London | ||
| 504 | |a Lopez-Ibor, J.J., (1950) La Angustia Vital, Patologia General Psicosomatica, , Paz Montalvo: Madrid | ||
| 504 | |a Sachar, E.J., Hellman, L., Fukushima, D.K., Gallagher, T.F., Cortisol production in depressive illness: A clinical and biochemical clarification (1970) Arch Gen Psychiatry, 23, pp. 289-298 | ||
| 504 | |a Gold, P.W., Chrousos, G., Kellner, C., Post, R., Roy, A., Augerinos, P., Schulte, H., Loriaux, D.L., Psychiatric implications of basic and clinical studies with corticotropin-releasing factor (1984) Am J Psychiatry, 141, pp. 619-627 | ||
| 504 | |a Gold, P.W., Goodwin, F.K., Chrousos, G.P., Clinical and biochemical manifestations of depression: Relation to the neurobiology of stress (Part 1 of 2 parts) (1988) N Engl J Med, 319, pp. 348-353 | ||
| 504 | |a Gold, P.W., Goodwin, F.K., Chrousos, G.P., Clinical and biochemical manifestations of depression: Relation to the neurobiology of stress (Part 2 of 2 parts) (1988) N Engl J Med, 319, pp. 413-420 | ||
| 504 | |a Kling, M.A., Geracioti, T.D., Licinio, J., Michelson, D., Oldfield, E.H., Gold, P.W., Effects of electroconvulsive therapy on the CRH-ACTH-cortisol system in melancholic depression: Preliminary findings (1994) Psychopharmacol Bull, 30, pp. 489-494 | ||
| 504 | |a Dorn, L.D.B.E., Dubbert, B.L., Simpson, S.-E., Friedman, T., Kling, M., Gold, P.W., Ghrousos, G.P., Psychopathology in patients with endogenous Cushing's syndrome: Atypical or melancholic features (1995) Clin Endocrinol, 43, pp. 433-442 | ||
| 504 | |a Demitrack, M.A., Dale, J.K., Straus, S.E., Laue, L., Listwak, S.J., Kruesi, M.J., Chrousos, G.P., Gold, P.W., Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome (1991) J Clin Endocrinol Metab, 73, pp. 1224-1234 | ||
| 504 | |a Veldhuis, J.D., Johnson, M.L., Returning to the roots of endocrinology: The challenge of evaluating in vivo glandular secretory activity (1990) Endocrinology, 127, pp. 2611-2617 | ||
| 504 | |a Szadoczky, E., Fazekas, I., Rihmer, Z., Arato, M., The role of psychosocial and biological variables in separating chronic and non-chronic major depression and early-late-onset dysthymia (1994) J Affect Disord, 32, pp. 1-11 | ||
| 504 | |a Vale, W., Spiess, J., Rivier, C., Rivier, J., Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin (1981) Science, 213, pp. 1394-1397 | ||
| 504 | |a Chen, R., Lewis, K.A., Perrin, M.H., Vale, W.W., Expression cloning of a human corticotropin-factor receptor (1993) Proc Natl Acad Sci USA, 90, pp. 8967-8971 | ||
| 504 | |a Jin, W.D., Boutillier, A.-L., Glucksman, M.J., Salton, S.R.J., Loeffler, J.-P., Roberts, J.L., Characterization of a corticotropin-releasing hormone-responsive element in the rat proopiomelanocortin gene promoter and molecular cloning of its binding protein (1994) Mol Endocrinology, 8, pp. 1377-1388 | ||
| 504 | |a Licinio, J., Bongiorno, P., Gold, P.W., Wong, M.-L., The gene encoding for the novel transacting factor proopiomelancortin corticotropin-releasing hormone responsive element binding protein 1 (PCRH-REB-1) is constitutively expressed in rat pituitary and in discrete brain regions containing CRH or CRH receptors: Pathophysiological implications (1995) Endocrinology, 136, pp. 4709-4712 | ||
| 504 | |a Fibiger, H.C., Phillips, A.G., Role of catecholamine transmitters in brain reward systems: Implications for the neurobiology of affect (1987) Brain Reward Systems and Abuse: Seventh International Berzelius Symposium, pp. 61-74. , Engel J, Oreland L (eds). Raven Press: New York | ||
| 504 | |a Blackburn, J.R., Pfaus, J.G., Phillips, A.G., Dopamine functions in appetitive and defensive behaviours (1992) Prog Neurobiol, 39, pp. 247-279 | ||
| 504 | |a Willner, P., Dopamine and depression: A review of recent evidence. I. Empirical studies (1983) Brain Res, 287, pp. 211-224 | ||
| 504 | |a Willner, P., Dopamine and depression: A review of recent evidence. III. The effects of antidepressant treatments (1983) Brain Res, 287, pp. 237-246 | ||
| 504 | |a Fouriezos, G., Hansson, P., Wise, R.A., Neuroleptic-induced attenuation of brain stimulation reward in rats (1978) J Comp Physiol Psychol, 92, pp. 661-671 | ||
| 504 | |a Gambarana, C., Ghiglieri, O., Taddei, I., Tagliamonte, A., De Montis, M.G., Imipramine and fluoxetine prevent the stress-induced escape deficits in rats through a distinct mechanism of action (1995) Behav Pharmacol, 6, pp. 66-73 | ||
| 504 | |a Serra, G., Collu, M., D'Aquila, P.S., Gessa, G.L., Role of the mesolimbic dopamine system in the mechanism of action of antidepressants (1992) Pharmacol Toxicol, 1, pp. 72-85 | ||
| 504 | |a D'Haenen, H., Bossuyt, A., Mertens, J., Bossuyt, P.G., Gijsemans, M., Kaufman, L., SPECT imaging of serotonin2 receptors in depression (1992) Psychiatry Res, 45, pp. 227-237 | ||
| 504 | |a George, M.S., SPECT and PET imaging in mood disorders (1993) J Clin Psychiatry, 54, pp. 6-13 | ||
| 504 | |a Thomas, P., Vaiva, G., Samaille, E., Maron, M., Alaix, C., Steinling, M., Goudemand, M., Cerebral blood flow in major depression and dysthymia (1993) J Affect Disord, 29, pp. 235-242 | ||
| 504 | |a Davons, P., Anquier, P., Grignon, S., Neukirch, H.C., A prospective study of depression in French patients with Parkinson's disease. The Depar Study (1995) Eur J Neurol, 2, pp. 455-461 | ||
| 504 | |a Forstl, H., Burns, A., Luthert, P., Cairns, N., Lantos, P., Levy, R., Clinical and neuropathological correlates of depression in Alzheimer's disease (1992) Psychol Med, 22, pp. 877-884 | ||
| 504 | |a Starkstein, S.E., Vazquez, S., Migliorelli, R., Teson, A., Sabe, L., Leiguarda, R., A single-photon emission computed tomographic study of anosognosia in Alzheimer's disease (1995) Arch Neurol, 52, pp. 415-420 | ||
| 504 | |a Eastwood, M.R., Rifat, S.L., Nobbs, H., Ruderman, J., Mood disorder following cerebrovascular accident (1989) Br J Psychiatry, 154, pp. 195-200 | ||
| 504 | |a Burvill, P.W., Johnson, G.A., Jamrozik, K.D., Anderson, C.S., Stewart, W.E., Chakera, T.M., Prevalence of depression after stroke: The Perth Community Stroke Study (1995) Br J Psychiatry, 166, pp. 320-327 | ||
| 504 | |a Morris, P.L., Robinson, R.G., Raphael, B., Prevalence and course of depressive disorders in hospitalized stroke patients (1990) Int J Psychiatry Med, 20, pp. 349-364 | ||
| 504 | |a Bolla, W.K., Robinson, R.G., Starkstein, S.E., Boston, J., Price, T.R., Lateralization of dementia of depression in stroke patients (1989) Am J Psychiatry, 146, pp. 627-634 | ||
| 504 | |a Robinson, R.G., Bolla, W.K., Kaplan, E., Lipsey, J.R., Price, T.R., Depression influences intellectual impairment in stroke patients (1986) Br J Psychiatry, 148, pp. 541-547 | ||
| 504 | |a Morris, P.L., Robinson, R.G., Andrzejewski, P., Samuels, J., Price, T.R., Association of depression with 10-year poststroke mortality (1993) Am J Psychiatry, 150, pp. 124-129 | ||
| 504 | |a Lipsey, J.R., Robinson, R.G., Pearlson, G.D., Rao, K., Price, T.R., Nortriptyline treatment of post-stroke depression; a double-blind study (1984) Lancet, 1, pp. 297-300 | ||
| 504 | |a Schubert, D.S., Foliart, R.H., Increased depression in multiple sclerosis patients. A meta-analysis (1993) Psychosomatics, 34, pp. 124-130 | ||
| 504 | |a Cazzulo, C.L., Smeraldi, E., Gasperini, M., Caputo, D., Preliminary correlations between primary affective disorders and multiple sclerosis (1983) New Trends in Multiple Sclerosis Research, pp. 57-62. , Cazzulo CE (ed). Masson Italia: Milano | ||
| 504 | |a Beatty, W.W., Cognitive and emotional disturbances in multiple sclerosis (1993) Neurol Clin, 11, pp. 189-204 | ||
| 504 | |a Kahana, E., Leibowitz, U., Alter, M., Cerebral multiple sclerosis (1971) Neurology, 21, pp. 1179-1185 | ||
| 504 | |a Mendez, M.F., Cummings, J.L., Benson, D.F., Depression in epilepsy: Significance and phenomology (1986) Arch Neurol, 43, pp. 766-770 | ||
| 504 | |a Thompson, P.M., Batzel, L.W., Wilkus, R.J., Millon Clinical Multiaxial Inventory assessments of patients manifesting either psychogenic or epileptic seizures (1992) J Epilepsy, 5, pp. 226-230 | ||
| 504 | |a Altshuler, L.L., Devinsky, O., Post, R.M., Theodore, W., Depression, anxiety and temporal lobe epilepsy: Laterality of focus and symptoms (1990) Arch Neurol, 47, pp. 284-288 | ||
| 504 | |a Robertson, M.M., Trimble, M.R., Townsend, H.R., Phenomenology of depression in epilepsy (1987) Epilepsia, 28, pp. 364-372 | ||
| 504 | |a Robertson, M.M., Depression in patients with epilepsy reconsidered (1988) Recent Advances in Epilepsy, pp. 205-240. , Pedley TA, Meldrom BS (eds). Churchill Livingston: Edinburgh | ||
| 504 | |a Robertson, M.M., Affect and mood in epilepsy: An overview with a focus on depression (1992) Acta Neurol Scand Suppl, 140, pp. 127-132 | ||
| 504 | |a Robertson, M.M., Channon, S., Baker, J., Depressive symptomatology in a general hospital sample of outpatients with temporal lobe epilepsy: A controlled study (1994) Epilepsia, 35, pp. 771-777 | ||
| 504 | |a Robertson, M.M., Coppen, A., Trimble, M.R., The dexamethasone suppression test in medicated epileptic patients (1986) Biol Psychiatry, 21, pp. 225-228 | ||
| 504 | |a Ojemann, L.M., Friel, P.N., Trejo, W.J., Dudley, D.L., Effect of doxepin on seizure frequency in depressed epileptic patients (1983) Neurology, 33, pp. 646-648 | ||
| 504 | |a Robertson, M.M., Trimble, M.R., The treatment of depression in patients with epilepsy. A double-blind trial (1985) J Affect Disord, 9, pp. 127-136 | ||
| 504 | |a Gureje, O., Interictal psychopathology in epilepsy. Prevalence and pattern in a Nigerian clinic (1991) Br J Psychiatry, 158, pp. 700-705 | ||
| 504 | |a Karfo, K., Vécu de l'Epilepsie Grand Mal au Sénégal (1991) Thèse Doct, 18, p. 137 | ||
| 504 | |a Canals, J., Marti, H.C., Fernandez, B.J., Domenech, E., A longitudinal study of depression in an urban Spanish pubertal population (1995) Eur Child Adolesc Psychiatry, 4, pp. 102-111 | ||
| 504 | |a Garrison, C.Z., Addy, C.L., Jackson, K.L., McKeown, R.E., Waller, J.L., Major depressive disorder and dysthymia in young adolescents (1992) Am J Epidemiol, 135, pp. 792-802 | ||
| 504 | |a Carlson, G.A., Rapport, M.D., Kelly, K.L., Pataki, C.S., Methylphenidate and desipramine in hospitalized children with co-morbid behavior and mood disorders: Separate and combined effects on behavior and mood (1995) J Child Adolesc Psychopharmacol, 5, pp. 191-204 | ||
| 504 | |a Kovacs, M., Akiskal, H.S., Gatsonis, C., Parrone, P.L., Childhood-onset dysthymic disorder: Clinical features and prospective naturalistic outcome (1994) Archs Gen Psychiatry, 51, pp. 365-374 | ||
| 504 | |a De Bellis, M., Lefter, L., Trickett, P.K., Putnam, F.J., Urinary catecholamine excretion in sexually abused girls (1994) J Am Acad Child Adolesc Psychiatry, 33, pp. 320-327 | ||
| 504 | |a Linden, M., Hautzinger, M., (1996) Vernhaltenstherapie: Techniken, Einzelverfahrer und Behandlungsanleitungen, , Springer-Verlag: Berlin | ||
| 504 | |a Markowitz, J.C., Psychotherapy of dysthymia (1994) Am J Psychiatry, 151, pp. 1114-1121 | ||
| 504 | |a Keller, M.B., Shapiro, R.W., Double depression: Superimposition of acute depressive episodes on chronic depressive disorders (1982) Am J Psychiatry, 139, pp. 438-442 | ||
| 504 | |a Rowan, P.R., Paykel, E.S., Parker, R.R., Phenelzine and amitriptyline: Effects on symptoms of neurotic depression (1982) Br J Psychiatry, 140, pp. 475-483 | ||
| 504 | |a Davidson, J.R., Giller, E.L., Zisook, S., Overall, J.E., An efficacy study of isocarboxazid and placebo in depression, and its relationship to depressive nosology (1988) Arch Gen Psychiatry, 45, pp. 120-127 | ||
| 504 | |a Kocsis, J.H., Frances, A.J., Voss, C., Mann, J.J., Mason, B.J., Sweeney, J., Imipramine treatment for chronic depression (1988) Arch Gen Psychiatry, 45, pp. 253-257 | ||
| 504 | |a Lecrubier, Y., Clinical utility of venlafaxine in comparison with other antidepressants (1995) Int Clin Psychopharmacol, 2, pp. 29-35 | ||
| 504 | |a Kocsis, J.H., Thase, M.E., Koran, L., Halbreich, U., Yonkers, K., (1994) Pharmacotherapy of 'Pure' Dysthymia: Setraline Versus Imipramine and Placebo, , Elsevier, 7th edn ECNP, Jerusalem | ||
| 504 | |a Paykel, E.S., Rowan, P.R., Parker, R.R., Bhat, A.V., Response to phenelzine and amitriptyline in subtypes of outpatient depression (1982) Arch Gen Psychiatry, 39, pp. 1041-1049 | ||
| 504 | |a Keller, M.B., Harrison, W., Fawcett, J.A., Gelenberg, A., Hirschfeld, R.M., Klein, D., Kocsis, J.H., Schatzberg, A., Treatment of chronic depression with sertraline or imiprarnine: Preliminary blinded response rates and high rates of undertreatment in the community (1995) Psychopharmacol Bull, 31, pp. 205-212 | ||
| 504 | |a Boyer, P., Lecrubier, Y., Puech, A., Treatment of dysthymia with low doses of amisulpride versus amineptine (1992) Clin Neuropharmacol, 15, pp. 1B-23B | ||
| 504 | |a Smeraldie, E., Haefele, E., Crespi, G., Casabei, G., Biondi, F., Vigorelli, E., Amisulpride versus fluoxetine in dysthymia: Preliminary results of a double-blind comparative study (1996) Eur Psychiatry, 11, pp. 141s-143s | ||
| 504 | |a Kocsis, J.H., Friedman, R.A., Markowitz, J.C., Miller, N., Gniwesch, L., Bram, J., Stability of remission during tricyclic antidepressant continuation therapy for dysthymia (1995) Psychopharmacol Bull, 31, pp. 213-216 | ||
| 520 | 3 | |a Dysthymia is characterized by long-lasting periods of lowered mood. Epidemiological studies in the USA and Europe have demonstrated that the prevalence of dysthymia is at least 3% of the general population. Its pervasive occurrence makes dysthymia a public health problem worldwide. One feature of this disorder is its co-occurrence with medical and neurological disorders. A World Health Organization meeting on dysthymia in neurological disorders was held in Geneva, 1-3 July 1996 to address this topic. Some of the major goals of this meeting were to clarify the definition of dysthymia in the presence of neurological disorders and to evaluate current research in the field, to point out new areas for investigation, and to discuss current psychological and pharmacological treatments for dysthymia in neurological disorders. The potential roles of neuroendocrine and molecular mechanisms in dysthymia were identified through specific problems related to dysthymia occurring in disorders such as Parkinson's disease, Alzheimer's disease, stroke, multiple sclerosis and epilepsy. This meeting provided direction and opportunity for future studies in the under-recognized and under-investigated relationship between dysthymia and neurological disorders. |l eng | |
| 593 | |a University of California, San Diego, School of Medicine, United States | ||
| 593 | |a WHO Secretariat, Div. Mental Hlth. Prev. Substance A., Geneva, Switzerland | ||
| 593 | |a Multiple Sclerosis Unit, Pro Juventude Found. Don Carlo G., Piazza Duse 1, 20122 Milan, Italy | ||
| 593 | |a Departmento de Psiquitria, Faculdade de Medicina, Universidade de Sao Paulo, Caixa Postal 8091, 01000 Sao Paulo, SP, Brazil | ||
| 593 | |a Hôpital de la Salpetriere, 47 Blvd de l'Hôpital, 75651 Paris Cedex 13, France | ||
| 593 | |a Molecular Psychiatry | ||
| 593 | |a Freie Universität Berlin, Psychiatrische Klinik und Poliklinik, Eschenelle 3, 14050 Berlin, Germany | ||
| 593 | |a Hospital Clinico San Carlos, Complutense University, Madrid, Spain | ||
| 593 | |a Ctr. Hospitalo-Universitaire de Fann, Service de Neurologie, BP 503, Dakar, Senegal | ||
| 593 | |a 'Bernard B Brodie' Dept. Neurosci., Center for Neuropharmacology, CNR and Universiti di Cagliari, Via Porcell, 4, 09124 Cagliari, Italy | ||
| 593 | |a University College London, Academic Department of Psychiatry, Middlesex Hospital, Mortimer St, London W1N 8AA, United Kingdom | ||
| 593 | |a Department of Psychiatry, Univ. of Iowa Hospitals and Clinics, Iowa City, Iowa 52242-1057, United States | ||
| 593 | |a Dept. Neuropsychiat. Neuropsychol., Raul Carrera Inst. of Neurol. Res., Montaneses 2325, 1428 Buenos Aires, Argentina | ||
| 593 | |a General Psychiatry Service, University of Lille II, USN-B, 6 av du Pr Laguesse, CHRU-Lille Cedex, France | ||
| 593 | |a Institute of Mental Health, Beijing Medical University, 51 Huayuanbeilu, Beijing 100083, China | ||
| 593 | |a Clinical Neuroendocrinology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892-1284, United States | ||
| 593 | |a Unit on Clinical Research, Intramural Research Program, National Institute of Mental Health, Bethesda, MD 20892-1284, United States | ||
| 690 | 1 | 0 | |a ALZHEIMER'S DISEASE |
| 690 | 1 | 0 | |a CLASSIFICATION |
| 690 | 1 | 0 | |a CORTICOTROPIN-RELEASING HORMONE |
| 690 | 1 | 0 | |a DOPAMINE |
| 690 | 1 | 0 | |a DYSTHYMIA |
| 690 | 1 | 0 | |a EPILEPSY |
| 690 | 1 | 0 | |a IMAGING TECHNIQUES |
| 690 | 1 | 0 | |a MULTIPLE SCLEROSIS |
| 690 | 1 | 0 | |a NERVOUS SYSTEM DISEASES |
| 690 | 1 | 0 | |a PARKINSON'S DISEASE |
| 690 | 1 | 0 | |a STROKE |
| 690 | 1 | 0 | |a CLASSIFICATION |
| 690 | 1 | 0 | |a CONFERENCE PAPER |
| 690 | 1 | 0 | |a DYSTHYMIA |
| 690 | 1 | 0 | |a HUMAN |
| 690 | 1 | 0 | |a NEUROLOGIC DISEASE |
| 690 | 1 | 0 | |a WORLD HEALTH ORGANIZATION |
| 690 | 1 | 0 | |a DYSTHYMIC DISORDER |
| 690 | 1 | 0 | |a HUMANS |
| 690 | 1 | 0 | |a NERVOUS SYSTEM DISEASES |
| 690 | 1 | 0 | |a WORLD HEALTH ORGANIZATION |
| 700 | 1 | |a Bolis, C.L. | |
| 700 | 1 | |a Cazzullo, C. | |
| 700 | 1 | |a Costa E Silva, J.A. | |
| 700 | 1 | |a Gentil, V. | |
| 700 | 1 | |a Lecrubier, Y. | |
| 700 | 1 | |a Licinio, J. | |
| 700 | 1 | |a Linden, M. | |
| 700 | 1 | |a Lopez-Ibor, J.J. | |
| 700 | 1 | |a Ndiaye, I.P. | |
| 700 | 1 | |a Pani, L. | |
| 700 | 1 | |a Prilipko, L. | |
| 700 | 1 | |a Robertson, M.M. | |
| 700 | 1 | |a Robinson, R.G. | |
| 700 | 1 | |a Starkstein, S.E. | |
| 700 | 1 | |a Thomas, P. | |
| 700 | 1 | |a Wang, Y. | |
| 700 | 1 | |a Wong, M.-L. | |
| 773 | 0 | |d 1996 |g v. 1 |h pp. 478-491 |k n. 6 |p Mol. Psychiatry |x 13594184 |w (AR-BaUEN)CENRE-6164 |t Molecular Psychiatry | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030325019&partnerID=40&md5=a333b059f4413ad955ceac01437a0823 |y Registro en Scopus |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_13594184_v1_n6_p478_Akiskal |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_13594184_v1_n6_p478_Akiskal |y Registro en la Biblioteca Digital |
| 961 | |a paper_13594184_v1_n6_p478_Akiskal |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 79732 | ||